Terms: = Uterine cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
19 results:
1. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract] [Full Text] [Related]
3. Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
Huang H; Nie CP; Liu XF; Song B; Yue JH; Xu JX; He J; Li K; Feng YL; Wan T; Zheng M; Zhang YN; Ye WJ; Li JD; Li YF; Li JY; Cao XP; Liu ZM; Zhang XS; Liu Q; Zhang X; Liu JH; Li J
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35727633
[TBL] [Abstract] [Full Text] [Related]
4. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.
Shi F; Su J; Wang J; Liu Z; Wang T
Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310
[TBL] [Abstract] [Full Text] [Related]
5. Association of homozygous variants of STING1 with outcome in human cervical cancer.
Lubbers JM; Koopman B; de Klerk-Sluis JM; van Rooij N; Plat A; Pijper H; Koopman T; van Hemel BM; Hollema H; Wisman B; Nijman HW; de Bruyn M
Cancer Sci; 2021 Jan; 112(1):61-71. PubMed ID: 33040406
[TBL] [Abstract] [Full Text] [Related]
6. Propranolol selectively inhibits cervical cancer cell growth by suppressing the cgmp/PKG pathway.
Gong L; Lei Y; Tan X; Dong Y; Luo Z; Zhang D; Han S
Biomed Pharmacother; 2019 Mar; 111():1243-1248. PubMed ID: 30841438
[TBL] [Abstract] [Full Text] [Related]
7. TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients.
Zom GG; Welters MJ; Loof NM; Goedemans R; Lougheed S; Valentijn RR; Zandvliet ML; Meeuwenoord NJ; Melief CJ; de Gruijl TD; Van der Marel GA; Filippov DV; Ossendorp F; Van der Burg SH
Oncotarget; 2016 Oct; 7(41):67087-67100. PubMed ID: 27564262
[TBL] [Abstract] [Full Text] [Related]
8. Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
Horikawa N; Baba T; Matsumura N; Murakami R; Abiko K; Hamanishi J; Yamaguchi K; Koshiyama M; Yoshioka Y; Konishi I
BMC Cancer; 2015 Oct; 15():739. PubMed ID: 26482555
[TBL] [Abstract] [Full Text] [Related]
9. Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.
Uzawa K; Kasamatsu A; Baba T; Usukura K; Saito Y; Sakuma K; Iyoda M; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H
Cancer Med; 2013 Feb; 2(1):40-9. PubMed ID: 24133626
[TBL] [Abstract] [Full Text] [Related]
10. A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.
Demurtas OC; Massa S; Ferrante P; Venuti A; Franconi R; Giuliano G
PLoS One; 2013; 8(4):e61473. PubMed ID: 23626690
[TBL] [Abstract] [Full Text] [Related]
11. Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol.
Rutella S; Iudicone P; Bonanno G; Fioravanti D; Procoli A; Lavorino C; Foddai ML; Lorusso D; Martinelli E; Vacca M; Ipsevich F; Nuti M; Scambia G; Pierelli L
Cytotherapy; 2012 Aug; 14(7):841-50. PubMed ID: 22563888
[TBL] [Abstract] [Full Text] [Related]
12. Urinary cyclic gmp after treatment of gynecological cancer. A prognostic marker of clinical outcome.
Orbo A; Hanevik M; Jaeger R; Van Heusden S; Sager G
Anticancer Res; 2007; 27(4C):2591-6. PubMed ID: 17695420
[TBL] [Abstract] [Full Text] [Related]
13. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract] [Full Text] [Related]
14. Relaxin: a pleiotropic hormone.
Bani D
Gen Pharmacol; 1997 Jan; 28(1):13-22. PubMed ID: 9112071
[TBL] [Abstract] [Full Text] [Related]
15. Attenuation of human chorionic gonadotropin release by nitric oxide in choriocarcinoma cell lines.
Myat-Thanda ; Hitsumoto Y; Saheki S; Kitagawa H; Yano J; Matsuura S
J Endocrinol; 1996 Aug; 150(2):243-53. PubMed ID: 8869591
[TBL] [Abstract] [Full Text] [Related]
16. Cellular changes in HeLa cells and cervix cells after treatment with cyclic nucleotides.
Busse E; Zimmer G; Bartsch O; Kornhuber B
Oncology; 1993; 50(4):241-4. PubMed ID: 8388554
[TBL] [Abstract] [Full Text] [Related]
17. Effects of adenine nucleotides on choriogonadotropin alpha and beta subunit synthesis.
Otani F; Otani T; Boime I
Biochem Biophys Res Commun; 1989 Apr; 160(1):6-11. PubMed ID: 2469421
[TBL] [Abstract] [Full Text] [Related]
18. Regulation of estrogen receptor levels in endometrial cancer cells.
Gurpide E; Blumenthal R; Fleming H
Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
[TBL] [Abstract] [Full Text] [Related]
19. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic gmp: a potential marker for cancer treatment.
Turner GA; Ellis RD; Guthrie D; Latner AL; Monaghan JM; Ross WM; Skillen AW; Wilson RG
J Clin Pathol; 1982 Aug; 35(8):800-6. PubMed ID: 6286732
[TBL] [Abstract] [Full Text] [Related]
